Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Webinar | The Business of the Hatch-Waxman Act

Wednesday, May 20th, 2020, 1:30 pm EDT

Webinar | The Business of the Hatch-Waxman Act

This webinar took place on: Wednesday, May 20th, 2020, 1:30 pm EDT

This webinar has ended.

The Hatch-Waxman Act provides a well-known framework that benefits innovators and generics alike. However, to take full advantage of its benefits and to mitigate its risks, businesses must be properly counseled to develop and maximize both their short-term and long-term strategies. That takes more than simply planning for litigation.

In this webinar, life sciences attorneys Chad Shear and Betsy Flanagan, who have counseled clients through strategic issues arising out of the Hatch-Waxman Act for their blockbuster products in the pharmaceutical industry from before FDA approval through litigation, will review key provisions of the Hatch-Waxman Act with a focus on strategies for counseling the business to maximize value and mitigate risk. Topics will include regulatory exclusivities, patent term extension, patent type and Orange Book listings, the 30-month stay, generic entry scenarios, and best practices for litigation planning.

Click the link to download a copy of the webinar slides.

Presenters: Chad Shear, Betsy Flanagan

Related Services
Related Industries
Related Offices